Influence of trial sample size on treatment effect estimates: meta-epidemiological study

A Dechartres, L Trinquart, I Boutron, P Ravaud - Bmj, 2013 - bmj.com
Objective To assess the influence of trial sample size on treatment effect estimates within
meta-analyses. Design Meta-epidemiological study. Data sources 93 meta-analyses (735 …

Empirical evidence of study design biases in randomized trials: systematic review of meta-epidemiological studies

MJ Page, JPT Higgins, G Clayton, JAC Sterne… - PloS one, 2016 - journals.plos.org
Objective To synthesise evidence on the average bias and heterogeneity associated with
reported methodological features of randomized trials. Design Systematic review of meta …

RoB 2: a revised tool for assessing risk of bias in randomised trials

JAC Sterne, J Savović, MJ Page, RG Elbers… - bmj, 2019 - bmj.com
Assessment of risk of bias is regarded as an essential component of a systematic review on
the effects of an intervention. The most commonly used tool for randomised trials is the …

Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysis

AU Kishan, Y Sun, H Hartman, TM Pisansky… - The lancet …, 2022 - thelancet.com
Background Randomised trials have investigated various androgen deprivation therapy
(ADT) intensification strategies in men receiving radiotherapy for the treatment of prostate …

Transfusion strategies in non-bleeding critically ill adults: a clinical practice guideline from the European Society of Intensive Care Medicine

AP Vlaar, S Oczkowski, S de Bruin, M Wijnberge… - Intensive care …, 2020 - Springer
Objective To develop evidence-based clinical practice recommendations regarding
transfusion practices in non-bleeding, critically ill adults. Design A task force involving 13 …

Evaluation of the Cochrane Collaboration's tool for assessing the risk of bias in randomized trials: focus groups, online survey, proposed recommendations and their …

J Savović, L Weeks, JAC Sterne, L Turner, DG Altman… - Systematic reviews, 2014 - Springer
Abstract Background In 2008, the Cochrane Collaboration introduced a tool for assessing
the risk of bias in clinical trials included in Cochrane reviews. The risk of bias (RoB) tool is …

Bias due to lack of patient blinding in clinical trials. A systematic review of trials randomizing patients to blind and nonblind sub-studies

A Hróbjartsson, F Emanuelsson… - International journal …, 2014 - academic.oup.com
Background: Blinding patients in clinical trials is a key methodological procedure, but the
expected degree of bias due to nonblinded patients on estimated treatment effects is …

Physiotherapy for pain and disability in adults with complex regional pain syndrome (CRPS) types I and II

KM Smart, MC Ferraro, BM Wand… - Cochrane Database …, 2022 - cochranelibrary.com
Background Complex regional pain syndrome (CRPS) is a painful and disabling condition
that usually manifests in response to trauma or surgery and is associated with significant …

Sublingual immunotherapy for peanut allergy: a randomized, double-blind, placebo-controlled multicenter trial

DM Fleischer, AW Burks, BP Vickery… - Journal of allergy and …, 2013 - Elsevier
BACKGROUND: There are presently no available therapeutic options for patients with
peanut allergy. OBJECTIVE: We sought to investigate the safety, efficacy, and immunologic …

Does vaginal progesterone prevent recurrent preterm birth in women with a singleton gestation and a history of spontaneous preterm birth? Evidence from a …

A Conde-Agudelo, R Romero - American journal of obstetrics and …, 2022 - Elsevier
Objective To assess the efficacy and safety of vaginal progesterone to prevent recurrent
preterm birth and adverse perinatal outcomes in singleton gestations with a history of …